Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
TGTX holding history
TG Therapeutics, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TGTX overviewAll 13F holders of TGTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,758
- Value
- $316.3K
- % of portfolio
- <0.1%
- Quarters held
- 4
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,758 | $316.3K | <0.1% | −19,935−77.6% | Reduced | Holders |
| Q1 2026 | 25,693 | $853.5K | <0.1% | +25,693 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −2,051,762−100.0% | Sold out | Holders |
| Q2 2024 | 2,051,762 | $36.5M | 0.1% | +2,051,762 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −1,020,102−100.0% | Sold out | Holders |
| Q4 2023 | 1,020,102 | $17.4M | <0.1% | +1,020,102 | New | Holders |